Cargando…
m(6)Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
PCIF1 (phosphorylated CTD interacting factor 1) is the first reported RNA N6,2′-O-dimethyladenosine (m(6)Am) methyltransferase. However, the pathological significance of PCIF1 and m(6)Am modification remains unknown. Here we find that both PCIF1 expression and m(6)Am modification are significantly e...
Autores principales: | Zhuo, Wei, Sun, Meng, Wang, Kun, Zhang, Lu, Li, Kai, Yi, Danyang, Li, Mengjie, Sun, Qiang, Ma, Xixi, Liu, Wei, Teng, Lisong, Yi, Chengqi, Zhou, Tianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124189/ https://www.ncbi.nlm.nih.gov/pubmed/35597784 http://dx.doi.org/10.1038/s41421-022-00395-1 |
Ejemplares similares
-
A Pan-Cancer Analysis of the Oncogenic and Immunogenic Role of m6Am Methyltransferase PCIF1
por: Jin, Ming-Zhu, et al.
Publicado: (2021) -
The CTBP2-PCIF1 complex regulates m(6)Am modification of mRNA in head and neck squamous cell carcinoma
por: Li, Kang, et al.
Publicado: (2023) -
Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA
por: Yu, Dan, et al.
Publicado: (2022) -
PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine
por: Wu, Yuting, et al.
Publicado: (2023) -
Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs
por: Yu, Dan, et al.
Publicado: (2022)